Overexpression of NNAT in ER + breast cancer cell lines suppresses proliferation and leads to elevated basal calcium levels and calcium release induced by thapsigargin, while NNAT CRISPRKO reduces intracellular calcium levels. Here, NNAT is linked to breast carcinoma.